+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Pazopanib"

From
Kidney Cancer Drugs - Global Strategic Business Report - Product Thumbnail Image

Kidney Cancer Drugs - Global Strategic Business Report

  • Report
  • February 2025
  • 148 Pages
  • Global
From
From
Kidney Cancer Drugs Market Report 2025 - Product Thumbnail Image

Kidney Cancer Drugs Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Soft Tissue Sarcoma Market Report 2025 - Product Thumbnail Image

Soft Tissue Sarcoma Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Sarcoma Drugs Market Report 2025 - Product Thumbnail Image

Sarcoma Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Renal Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Renal Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 180 Pages
  • Global
From
Soft Tissue Sarcoma - Pipeline Insight, 2024 - Product Thumbnail Image

Soft Tissue Sarcoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 250 Pages
  • Global
From
Gastrointestinal Stromal Tumors - Pipeline Insight, 2024 - Product Thumbnail Image

Gastrointestinal Stromal Tumors - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 85 Pages
  • Global
From
Synovial Sarcoma Pipeline Analysis Report - Product Thumbnail Image

Synovial Sarcoma Pipeline Analysis Report

  • Report
  • August 2024
  • 150 Pages
  • Global
From
Precision Cancer Therapeutics, 2022 - Product Thumbnail Image

Precision Cancer Therapeutics, 2022

  • Report
  • November 2022
  • 154 Pages
  • Global
From
From
From
From
Loading Indicator

Pazopanib is an oncology drug used to treat certain types of cancer. It is a tyrosine kinase inhibitor, meaning it works by blocking the action of certain enzymes that are involved in the growth and spread of cancer cells. Pazopanib is used to treat advanced renal cell carcinoma, a type of kidney cancer, and advanced soft tissue sarcoma, a type of cancer that affects the connective tissues. It is also used to treat other types of cancer, such as ovarian cancer and thyroid cancer. Pazopanib is available in tablet form and is taken orally. It is usually taken once daily, with or without food. Common side effects of pazopanib include nausea, vomiting, diarrhea, fatigue, and hair loss. Some companies in the pazopanib market include GlaxoSmithKline, Novartis, and Pfizer. Show Less Read more